pharmaphorum| News & views on pharma and biotech’s evolving future

R&D

Europe has the tools to fight superbugs. Let’s use them.

Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.

News

AstraZeneca and Daiichi Sankyo logos next to Datroway box

Datroway filed for TNBC in EU after data delay

Daiichi Sankyo and AstraZeneca have filed their first marketing application for TROP2-targeting Datroway in triple-negative breast cancer.

Market Access

Equity and Sustainability

News

Takeda plans filings for Sotyktu rival on new psoriasis data

Takeda intends to file for approval of its oral psoriasis therapy zasocitinib next year, with Bristol Myers Squibb's Sotyktu in its sights.

R&D

Black mouse in a lab on scientist's hand

FDA’s emerging framework to reduce animal testing: Implicati...

Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.

Featured Content

R&D

Europe has the tools to fight superbugs. Let’s use them.

Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.

Market Access

Equity and Sustainability

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Digital

pharmaphorum podcast Episode 232, Kate Eversole, Celine Parmentier, Emma Slade

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

R&D

Sponsored

Unlocking the future of obesity treatment

Obesity is more than a number on the scale, it’s a complex, malignant disease linked to diabetes, cardiovascular conditions, and even certain cancers.

Sales & Marketing

Lumanity white paper - person at top of mountain range

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Newsletters and Deep Dive
digital magazine

Latest News

News

Datroway filed for TNBC in EU after data delay

Daiichi Sankyo and AstraZeneca have filed their first marketing application for TROP2-targeting Datroway in triple-negative breast cancer.

News

Takeda plans filings for Sotyktu rival on new psoriasis data

Takeda intends to file for approval of its oral psoriasis therapy zasocitinib next year, with Bristol Myers Squibb's Sotyktu in its sights.

News

MSD claims two national priority vouchers; report

The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD drug candidates.

News

As year-end nears, pharma groups boost their pipelines

Bristol Myers Squibb, Sanofi, Pfizer, Roche, and Yarrow Bioscience all added to their pipelines this week in an end-of-year licensing deal flurry.

Views & Analysis

R&D

Europe has the tools to fight superbugs. Let’s use them.

Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.

R&D

FDA’s emerging framework to reduce animal testing: Implicati...

Exploring the strategic shift toward reducing reliance on non-human primates (NHPs) and other animal species in R&D.

Digital

Stethoscope and UK flag with NHS on wooden blocks spelled out on top

Six ways the NHS can become the UK’s greatest testbed for te...

There are six priorities that would turn the NHS into the UK’s flagship testbed for innovation.

Digital

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

Deep Dive

Market Access

Equity and Sustainability

Market Access

Mapping the pharma sector's path to net zero

Market Access

Pharma’s determined shift to more sustainable logistics

Market Access

Inside Sandoz: How women leaders are driving sustainability ...

White Papers & Webinar

Sales & Marketing

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Digital

White paper from Veeva on Clinical Data Industry Research

Sponsored

Data managers and CRAs warn of rising data quality risks due...

A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.

Sales & Marketing

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

R&D

A man stood on a rock looking towards the horizon

Sponsored

A New Framework to Engineer Breakthrough Value for Medicines

A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.

Podcasts & Video

Digital

On the future of AI in life sciences, with women at the helm

Dive into a conversation on women in AI, with: Kate Eversole, Pharma Brands; Celine Parmentier, Real Chemistry; and Emma Slade, Tangram Therapeutics.

R&D

Sponsored

Unlocking the future of obesity treatment

Obesity is more than a number on the scale, it’s a complex, malignant disease linked to diabetes, cardiovascular conditions, and even certain cancers.

Digital

pharmaphorum podcast Episode 231, Dr Alan Roth, Oxford Drug Design

On AI and computational support of biochemistry, with Alan R...

Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.

Digital

Balancing global consistency and local nuance: EVERSANA on A...

The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre

Partner Content

R&D

Partner Content

5th mRNA-Based Therapeutics Summit Europe

The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines

Market Access

VuuAI and Amiculum partner to transform content engagement i...

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat

R&D